相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
KLH conjugated synthetic peptide between 139-167 amino acids from the C-terminal region of human VIP.
- 亚型:
IgG
- 形态:
Liquid
- 保存条件:
Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
- 克隆性:
Polyclonal
- 标记物:
Unconjugated
- 适应物种:
Human
- 保质期:
12 months from the shipping date of the product.
- 抗原来源:
Human
- 目录编号:
GTX81846
- 级别:
Primary Antibodies
- 库存:
Available
- 供应商:
GeneTex
- 宿主:
Rabbit
- 应用范围:
WB, IHC-P, FACS
- 浓度:
Batch dependent (Please refer to the vial label for the specific concentration.)
- 靶点:
VIP
- 抗体英文名:
VIP antibody, C-term
- 抗体名:
VIP 抗体, C-term
- 规格:
400 μl
WB analysis of Jurkat cell lysate (35ug/lane) using GTX81846 VIP antibody, C-term.
IHC-P analysis of human prostate carcinoma using GTX81846 VIP antibody, C-term.
FACS analysis of jurkat cells using GTX81846 VIP antibody, C-term.
Top histogram : negative control
Bottom histogram : jurkat cells
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Assay of Radiolabeled VIP Binding and Hydrolysis by Antibodies
and resolved peaks characterized by protein chemistry methods. We describe here methods for preparation and purification of vasoactive intestinal (VIP) labeled at Tyr10 with 125 I, and the use of (Tyr10_125 I)VIP to characterize antibody binding and enzymatic
Molecular Cloning of Antiground-State Proteolytic Antibody Fragments
FV (scFV ) fragment of one such antibody. The recombinant L chain and the scFV display interactions with VIP typical of an antibody-combining site. Both molecules are efficient catalysts (8 ). The distinctive feature of catalytic hydrolysis of VIP
Site-Directed Mutagenesis of Antibody-Variable Regions
Introduction of mutations in antibody combining sites provides a powerful means to assess the functional role of individual residues and segments of the combining sites in interactions with antigen. Once cloned antibody fragments
技术资料暂无技术资料 索取技术资料










